Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study*

Author: Conte P.F.  

Publisher: Springer Publishing Company

ISSN: 0167-6806

Source: Breast Cancer Research and Treatment, Vol.68, Iss.2, 2001-07, pp. : 171-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content